| scholarly article | Q13442814 |
| P50 | author | Lars-Olof Wahlund | Q38637441 |
| Marianne Schultzberg | Q40543197 | ||
| Maria Eriksdotter | Q44908924 | ||
| Yvonne Freund-Levi | Q48275302 | ||
| Jan Palmblad | Q65768736 | ||
| P2093 | author name string | Inger Vedin | |
| Tommy Cederholm | |||
| Erik Hjorth | |||
| Hans Basun | |||
| Catharina Lindberg | |||
| Gerd Faxen-Irving | |||
| P433 | issue | 5 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| cerebrospinal fluid | Q54196 | ||
| inflammation | Q101991 | ||
| omega-3 fatty acid | Q191756 | ||
| P304 | page(s) | 481-490 | |
| P577 | publication date | 2009-05-12 | |
| P1433 | published in | Dementia and Geriatric Cognitive Disorders | Q15749436 |
| P1476 | title | Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study | |
| P478 | volume | 27 |
| Q36830364 | (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders. |
| Q37692220 | APP Function and Lipids: A Bidirectional Link |
| Q33349401 | Alzheimer's disease: clinical trials and drug development |
| Q52879007 | Apolipoprotein E genotype status affects habitual human blood mononuclear cell gene expression and its response to fish oil intervention. |
| Q33771834 | Biomarkers of oxidative damage and inflammation in Alzheimer's disease |
| Q34408888 | Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 |
| Q34777760 | Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity |
| Q34330929 | Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease. |
| Q37770005 | Current therapies and new strategies for the management of Alzheimer's disease. |
| Q37136498 | Cytokine Therapies in Neurological Disease |
| Q37698014 | DHA may prevent age-related dementia |
| Q39014590 | Dietary DHA and health: cognitive function ageing. |
| Q36457368 | Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype |
| Q38032965 | Dietary patterns: a novel approach to examine the link between nutrition and cognitive function in older individuals |
| Q21132327 | Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis |
| Q35885375 | Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease |
| Q35920548 | Epidemiology of Alzheimer disease |
| Q27021694 | Experimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases |
| Q47945490 | Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. |
| Q59118186 | Food for thought: how nutrition impacts cognition and emotion |
| Q47290017 | Impact of dietary fats on brain functions |
| Q39387457 | Is there a causal link between inflammation and dementia? |
| Q28730725 | Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging |
| Q37703299 | Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease. |
| Q36014708 | Nutrient intake and plasma β-amyloid. |
| Q91246348 | Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease |
| Q38243598 | Nutrition and brain aging: how can we move ahead? |
| Q34635830 | Omega-3 fatty acids EPA and DHA: health benefits throughout life |
| Q24185910 | Omega-3 fatty acids for the treatment of dementia |
| Q24595490 | Omega-3 fatty acids: potential role in the management of early Alzheimer's disease |
| Q38010556 | Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. |
| Q35542811 | Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment |
| Q38353525 | Role of fish oil in human health and possible mechanism to reduce the inflammation |
| Q47815645 | Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment |
| Q47188911 | Targeting Neuroinflammation to Treat Alzheimer's Disease. |
| Q91262891 | The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial |
| Q53347902 | Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. |
Search more.